CSL Behring United Kingdom

Focus on Rare Diseases

CSL Behring is committed to improving the quality of life for people with rare and serious diseases worldwide. This commitment is reflected in our support of programmes and activities for patients with rare plasma-protein related diseases, including bleeding disorders and primary immune deficiencies.

Adverse Event Reporting

Adverse events should be reported.

Reporting forms and information can be found at https://yellowcard.mhra.gov.uk . Adverse events should also be reported to CSL Behring UK Ltd. on 01444 447 405.

If you would like to contact CSL Behring for any other reason, please visit our Contact page to find the appropriate details.

Contact us

UK/CORP/18-0033j February 2019

Our Products

CSL Behring is committed to treating people with rare and serious medical conditions.

Find out more about our products

Our Patients

If you or a loved one is living with a rare or serious disease, see how our products may help.

Learn more

Our Company

Read about our commitment to improving the quality of life for those who use our therapies.

Learn more

How did it all start? Learn more about the roots of CSL Behring.

Discover our commitment to funding research and development of protein-based medicines.

Take a look at the range of products we offer here in the UK.

Focus on Rare Diseases

Adverse Event Reporting

Our Products

Our Patients

Our Company

Corporate

CSL Behring Worldwide